Exploratory Data Analysis of Genomic Sequence of Variants of SARS-CoV-2 Reveals Sequence Divergence and Mutational Localization.

Whole genome sequencing has rapidly progressed in recent years, with sequencing the SARS-CoV-2 genomes, making it a more reliable clinical tool for public health surveillance. This development has resulted in the production of a large amount of genomic data used for various types of genomic exploration. However, without a proper standard protocol, the usage of genomic data for analyzing various biological phenomena, such as mutation and evolution, may result in a propagating risk of using an unvalidated data set. This process could lead to irregular data being generated along with a high risk of altered analysis. Thus, the current study lays out the foundation for a preprocess pipeline using data analysis to analyze the genomic data set for its accuracy. We have used the recent example of SARS-CoV-2 to demonstrate the process overflow that can be utilized for various kinds of biological exploration such as understanding mutational events, evolutionary divergence, and speciation. Our analysis reveals a significant amount of sequence divergence in the gamma variant as compared with the reference genome thereby making the variant less infective and deadly. Moreover, we found regions in the genomic sequence that is more prone to mutational localization thereby altering the structural integrity of the virus resulting in a more reliable molecular viral mechanism. We believe that the current work will help for an initial check of the genomic data followed by the biological assessment of the process overflow which will be beneficial for the variant analysis and mutational uprising.